secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOVIE INC. (BIVI)
CIK:        0001580149
Form:       8-K
Filed at:   2024-10-29T23:59:59+00:00
Accession:  0001520138-24-000404
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioVie closes registered direct offering raising $3.24M gross proceeds at $2.83/share
--------------------------------------------------------------------------------

- Closed registered direct offering of 1,146,000 shares at $2.83/share, gross proceeds ~$3.24M.
- Net proceeds after fees of ~$419K are approx. $2.82M; funds for working capital and corporate purposes.
- ThinkEquity acted as sole placement agent; offering made under shelf registration S-3.
- BioVie is a clinical-stage company developing therapies for liver disease and neurological disorders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580149/000152013824000404/0001520138-24-000404-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580149/000152013824000404/bivi-20241029_8k.htm
  HTML page:      https://secwatch.observer/filing/0001520138-24-000404

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer